During the past decade, Samodzielny Publiczny Dzieciecy Szpital Kliniczny conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Samodzielny Publiczny Dzieciecy Szpital Kliniczny" #1 sponsor was "Takeda" with 6 trials, followed by "Shire" with 4 trials sponsored, "Baxalta now part of Shire" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Arla Foods" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samodzielny Publiczny Dzieciecy Szpital Kliniczny" #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Nutricia Foundation" with 1 trials as a collaborator, "Ovid Therapeutics Inc." with 1 trials as a collaborator and "Shire" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Samodzielny Publiczny Dzieciecy Szpital Kliniczny" are "Dravet Syndrome (DS)" (3 trials), "Epilepsy" (2 trials), "Hemophilia A" (2 trials), "Lennox Gastaut Syndrome (LGS)" (2 trials) and "Thrombotic Thrombocytopenic Purpura (TTP)" (2 trials). Many other conditions were trialed in "Samodzielny Publiczny Dzieciecy Szpital Kliniczny" in a lesser frequency.

Most popular intervention types in "Samodzielny Publiczny Dzieciecy Szpital Kliniczny" are "Drug" (11 trials), "Biological" (4 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Soticlestat" (4 trials), "Atomoxetine Hydrochloride" (2 trials), "ADVATE" (1 trials) and "ADYNOVI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Samodzielny Publiczny Dzieciecy Szpital Kliniczny" are 16 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Samodzielny Publiczny Dzieciecy Szpital Kliniczny". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Samodzielny Publiczny Dzieciecy Szpital Kliniczny, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Samodzielny Publiczny Dzieciecy Szpital Kliniczny, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".